Rituxan (rituximab) - Roche
Beyond Extranodal Site Count: Clinical and Anatomical Characterization of Primary Multifocal Extranodal Diffuse Large B-Cell Lymphoma. (PubMed, Eur J Haematol) - Oct 2, 2026 - "PMEN-DLBCL represents a distinct anatomical and clinical phenotype characterized by multifocal extranodal dissemination, preferential skeletal and deep visceral organ involvement, adverse baseline features, and inferior response quality. Specific organ involvement and spatial dissemination patterns appear more informative than extranodal site count alone, supporting further investigation of anatomical disease architecture in risk stratification of extranodal DLBCL." 
Journal • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Otorhinolaryngology
http://www.ncbi.nlm.nih.gov/pubmed/42823325
 
Anthi Bouchla; Artemis Zormpa; Christina Apostolopoulou; Georgia Karamanou; Ioulia Markaki; Periklis G Foukas; Pinelopi Vryttia; Sotirios G Papageorgiou; Thomas P Thomopoulos; Vasiliki Pappa
 
Oct 2, 2026
 
Prev Next